Boeing expects slower production increase of 787 Dreamliner because of parts shortages
Related Articles
-
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.
-
The Covid vaccine is dead! Long live the Covid vaccine ?!
Did you know that four years after the Great Covid Pandemonium erupted, vaccine mandates are still being enforced in the…What to read next: After the Thalidomide apology, where is the Covid vaccine apology? | Port Macquarie educator fired during Covid slams medical authoritarianism | The Covid show must go on! | Last of the Covid midwits
-
AstraZeneca admits its vaccine causes clotting: Why Covishield vaccine takers in India shouldn't panic
Global pharmaceutical manufacturer AstraZeneca has admitted that its COVID-19 vaccine, developed by researchers from the Oxford University, can cause a rare side effect of blood clotting and low platelet count after immunisation. In India, the same vaccine, called Covishield and manufactured by the Pune-based Serum Institute, has been administered through 175 crore doses. Understandably, this raises questions as to the safety of the jab all of us took. The company made this admission of a side...